Cargando…
Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm
Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angios...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822683/ https://www.ncbi.nlm.nih.gov/pubmed/36660212 http://dx.doi.org/10.14740/wjon1542 |
_version_ | 1784866003306414080 |
---|---|
author | Damouny, Mira Mansour, Subhi Khuri, Safi |
author_facet | Damouny, Mira Mansour, Subhi Khuri, Safi |
author_sort | Damouny, Mira |
collection | PubMed |
description | Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival. |
format | Online Article Text |
id | pubmed-9822683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98226832023-01-18 Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm Damouny, Mira Mansour, Subhi Khuri, Safi World J Oncol Review Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival. Elmer Press 2022-12 2022-12-24 /pmc/articles/PMC9822683/ /pubmed/36660212 http://dx.doi.org/10.14740/wjon1542 Text en Copyright 2022, Damouny et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Damouny, Mira Mansour, Subhi Khuri, Safi Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title | Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title_full | Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title_fullStr | Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title_full_unstemmed | Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title_short | Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm |
title_sort | primary angiosarcoma of the spleen: an aggressive neoplasm |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822683/ https://www.ncbi.nlm.nih.gov/pubmed/36660212 http://dx.doi.org/10.14740/wjon1542 |
work_keys_str_mv | AT damounymira primaryangiosarcomaofthespleenanaggressiveneoplasm AT mansoursubhi primaryangiosarcomaofthespleenanaggressiveneoplasm AT khurisafi primaryangiosarcomaofthespleenanaggressiveneoplasm |